July 12 (Reuters) - Juno Therapeutics Inc said U.S.
health regulators have removed a clinical hold on its cancer
drug trial that was put in place last week following the death
of three patients, sending its shares up about 28 percent in
extended trading.
Read more
No comments:
Post a Comment